(BG) Bunge - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: CH1300646267

Oils, Grains, Sugar, Ethanol, Flour

BG EPS (Earnings per Share)

EPS (Earnings per Share) of BG over the last years for every Quarter: "2020-03": -1.2966960326034, "2020-06": 3.4353485380794, "2020-09": 1.7637159205655, "2020-12": 3.6979865771812, "2021-03": 5.5174849829463, "2021-06": 2.3709719675138, "2021-09": 4.2808836583003, "2021-12": 1.5197368421053, "2022-03": 4.478557279641, "2022-06": 1.337031154773, "2022-09": 2.4931062332248, "2022-12": 2.2105263157895, "2023-03": 4.1506856512373, "2023-06": 4.0872811957466, "2023-09": 2.4666555127106, "2023-12": 4.1904761904762, "2024-03": 1.6827586206897, "2024-06": 0.48887734207167, "2024-09": 1.554743868259, "2024-12": 4.3114839454519, "2025-03": 1.4844048865723, "2025-06": 2.6029411764706,

BG Revenue

Revenue of BG over the last years for every Quarter: 2020-03: 9173, 2020-06: 9462, 2020-09: 10159, 2020-12: 12610, 2021-03: 12961, 2021-06: 15391, 2021-09: 14117, 2021-12: 16683, 2022-03: 15880, 2022-06: 17933, 2022-09: 16759, 2022-12: 16660, 2023-03: 15328, 2023-06: 15049, 2023-09: 14227, 2023-12: 14936, 2024-03: 13417, 2024-06: 13241, 2024-09: 12908, 2024-12: 13542, 2025-03: 11643, 2025-06: 12769,

Description: BG Bunge

Bunge Limited (NYSE:BG) is a global agribusiness and food company with a diverse portfolio of operations across four key segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The companys extensive range of products and services caters to various industries, including animal feed, food manufacturing, and biofuel production.

From a financial perspective, Bunges market capitalization stands at approximately $15.7 billion, with a price-to-earnings ratio of 10.07 and a forward P/E of 11.75. The companys return on equity is around 10.77%, indicating a relatively stable and profitable business model. To further analyze the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow margin can be examined. For instance, Bunges revenue growth has been driven by its diversified portfolio and strategic acquisitions, while its gross margin has been influenced by factors such as commodity prices and operational efficiency.

In terms of its segments, Agribusiness is a significant contributor to Bunges revenue, driven by the demand for oilseeds, grains, and other agricultural commodities. The Refined and Specialty Oils segment benefits from the growing demand for healthy and sustainable food products, while the Milling segment provides a range of products for the food industry. The Sugar and Bioenergy segment is influenced by factors such as sugar prices, ethanol demand, and renewable energy policies. To evaluate the companys prospects, KPIs such as segment-wise revenue growth, operating profit margin, and capital expenditure can be analyzed.

Some additional KPIs that can be used to assess Bunges performance include its debt-to-equity ratio, interest coverage ratio, and dividend yield. The companys dividend yield is around 2-3%, which is relatively attractive for income-seeking investors. Furthermore, Bunges commitment to sustainability and environmental stewardship can be evaluated through metrics such as its greenhouse gas emissions reduction targets and water conservation initiatives.

BG Stock Overview

Market Cap in USD 16,835m
Sub-Industry Agricultural Products & Services
IPO / Inception 2001-08-02

BG Stock Ratings

Growth Rating -7.09%
Fundamental 48.5%
Dividend Rating 83.9%
Return 12m vs S&P 500 -26.4%
Analyst Rating 3.90 of 5

BG Dividends

Dividend Yield 12m 5.19%
Yield on Cost 5y 10.30%
Annual Growth 5y 6.21%
Payout Consistency 99.8%
Payout Ratio 36.6%

BG Growth Ratios

Growth Correlation 3m 32.6%
Growth Correlation 12m -32.3%
Growth Correlation 5y 36.1%
CAGR 5y -0.14%
CAGR/Max DD 3y 0.00
CAGR/Mean DD 3y -0.01
Sharpe Ratio 12m -0.93
Alpha -24.33
Beta 0.467
Volatility 28.30%
Current Volume 1201k
Average Volume 20d 1945.5k
Stop Loss 79.1 (-3.1%)
Signal -0.04

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (1.38b TTM) > 0 and > 6% of Revenue (6% = 3.05b TTM)
FCFTA 0.01 (>2.0%) and ΔFCFTA -4.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 21.75% (prev 14.06%; Δ 7.69pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.03 (>3.0%) and CFO 1.02b <= Net Income 1.38b (YES >=105%, WARN >=100%)
Net Debt (5.42b) to EBITDA (2.64b) ratio: 2.05 <= 3.0 (WARN <= 3.5)
Current Ratio 2.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (136.0m) change vs 12m ago -5.02% (target <= -2.0% for YES)
Gross Margin 6.27% (prev 6.88%; Δ -0.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 183.0% (prev 228.5%; Δ -45.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 4.81 (EBITDA TTM 2.64b / Interest Expense TTM 450.0m) >= 6 (WARN >= 3)

Altman Z'' 4.59

(A) 0.36 = (Total Current Assets 21.45b - Total Current Liabilities 10.38b) / Total Assets 31.15b
(B) 0.42 = Retained Earnings (Balance) 13.01b / Total Assets 31.15b
(C) 0.08 = EBIT TTM 2.16b / Avg Total Assets 27.79b
(D) 0.36 = Book Value of Equity 6.89b / Total Liabilities 19.20b
Total Rating: 4.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 48.45

1. Piotroski 3.50pt = -1.50
2. FCF Yield 0.83% = 0.42
3. FCF Margin 0.35% = 0.09
4. Debt/Equity 1.06 = 1.96
5. Debt/Ebitda 4.37 = -2.50
6. ROIC - WACC 4.50% = 5.62
7. RoE 13.28% = 1.11
8. Rev. Trend -93.15% = -4.66
9. Rev. CAGR -9.41% = -1.57
10. EPS Trend -27.10% = -0.68
11. EPS CAGR 1.58% = 0.16

What is the price of BG shares?

As of September 13, 2025, the stock is trading at USD 81.62 with a total of 1,200,986 shares traded.
Over the past week, the price has changed by -3.21%, over one month by -0.22%, over three months by +6.89% and over the past year by -12.38%.

Is Bunge a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Bunge (NYSE:BG) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 48.45 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BG is around 79.12 USD . This means that BG is currently overvalued and has a potential downside of -3.06%.

Is BG a buy, sell or hold?

Bunge has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy BG.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the BG price?

Issuer Target Up/Down from current
Wallstreet Target Price 89.8 10%
Analysts Target Price 89.8 10%
ValueRay Target Price 85.4 4.6%

Last update: 2025-09-11 04:33

BG Fundamental Data Overview

Market Cap USD = 16.84b (16.84b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 6.79b USD (last quarter)
P/E Trailing = 8.4829
P/E Forward = 9.7182
P/S = 0.331
P/B = 1.5469
P/EG = 1.7053
Beta = 0.648
Revenue TTM = 50.86b USD
EBIT TTM = 2.16b USD
EBITDA TTM = 2.64b USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 4.51b USD (from shortTermDebt, last quarter)
Debt = 11.55b USD (Calculated: Short Term 4.51b + Long Term 7.04b)
Net Debt = 5.42b USD (from netDebt column, last quarter)
Enterprise Value = 21.60b USD (16.84b + Debt 11.55b - CCE 6.79b)
Interest Coverage Ratio = 4.81 (Ebit TTM 2.16b / Interest Expense TTM 450.0m)
FCF Yield = 0.83% (FCF TTM 180.0m / Enterprise Value 21.60b)
FCF Margin = 0.35% (FCF TTM 180.0m / Revenue TTM 50.86b)
Net Margin = 2.71% (Net Income TTM 1.38b / Revenue TTM 50.86b)
Gross Margin = 6.27% ((Revenue TTM 50.86b - Cost of Revenue TTM 47.67b) / Revenue TTM)
Tobins Q-Ratio = 3.13 (Enterprise Value 21.60b / Book Value Of Equity 6.89b)
Interest Expense / Debt = 0.92% (Interest Expense 106.0m / Debt 11.55b)
Taxrate = 22.05% (336.0m / 1.52b)
NOPAT = 1.69b (EBIT 2.16b * (1 - 22.05%))
Current Ratio = 2.07 (Total Current Assets 21.45b / Total Current Liabilities 10.38b)
Debt / Equity = 1.06 (Debt 11.55b / last Quarter total Stockholder Equity 10.88b)
Debt / EBITDA = 4.37 (Net Debt 5.42b / EBITDA 2.64b)
Debt / FCF = 64.17 (Debt 11.55b / FCF TTM 180.0m)
Total Stockholder Equity = 10.38b (last 4 quarters mean)
RoA = 4.42% (Net Income 1.38b, Total Assets 31.15b )
RoE = 13.28% (Net Income TTM 1.38b / Total Stockholder Equity 10.38b)
RoCE = 12.42% (Ebit 2.16b / (Equity 10.38b + L.T.Debt 7.04b))
RoIC = 9.38% (NOPAT 1.69b / Invested Capital 17.98b)
WACC = 4.88% (E(16.84b)/V(28.39b) * Re(7.74%)) + (D(11.55b)/V(28.39b) * Rd(0.92%) * (1-Tc(0.22)))
Shares Correlation 3-Years: -90.91 | Cagr: -1.03%
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈597.2m ; Y1≈392.1m ; Y5≈179.3m
Fair Price DCF = 17.62 (DCF Value 3.52b / Shares Outstanding 200.1m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -93.15 | Revenue CAGR: -9.41%
Rev Growth-of-Growth: 4.11
EPS Correlation: -27.10 | EPS CAGR: 1.58%
EPS Growth-of-Growth: 46.05

Additional Sources for BG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle